How to Value a Company With Negative EBITDA: DCF, Add-Backs, and Comps

Valuing a company with negative EBITDA means setting aside earnings-based multiples (there is nothing positive to multiply) and reaching for one or more of five alternatives: revenue multiples, discounted cash flow, asset-based valuation, industry-specific performance metrics, and comparable transaction analysis. Serious analysts rarely rely on just one. They triangulate, because each method captures a different dimension of value and each has blind spots the others cover.

Before any of that, do the cleanup work.

Start With EBITDA Add-Backs

Check whether the negative EBITDA is real or inflated by one-time costs. An add-back removes expenses that distort recurring operating performance: legal settlements, relocation costs, severance from a single layoff, large technology upgrades, and the deal costs of a sale itself (advisory fees, legal fees, due diligence). A company showing negative $2 million EBITDA that spent $3 million on a one-time facility buildout has adjusted EBITDA of positive $1 million, and ordinary earnings multiples work from there.

Aggressive add-backs are one of the quickest ways to lose credibility with buyers and regulators. The SEC has warned that estimates of lost revenue are a non-GAAP measure and should not be used to normalize results in public filings. If “one-time” legal fees appear three years in a row, they are not one-time. Only after honest normalization still produces negative EBITDA should you move to the methods below.

Revenue-Based Valuation

The Enterprise Value-to-Revenue (EV/Revenue) multiple is the standard metric for companies without positive earnings. Enterprise value equals market capitalization plus total debt minus cash. Divide by annual revenue and you have a multiple that can be compared across similar companies. Revenue sits at the top of the income statement, so it is less sensitive to accounting choices around depreciation, stock-based compensation, or capitalization than any earnings figure.

Picking the right multiple is where this method lives or dies, because benchmarks vary enormously by sector. As of January 2026, price-to-sales ratios run roughly 11x for systems and application software, 7.3x for biotech, 5.6x for pharmaceuticals, and about 2x for general retail.1NYU Stern. Price to Sales Ratios – Revenue Multiples by Sector (US) A SaaS company and a grocery chain with identical $50 million revenue figures have very different implied enterprise values. Applying a generic “4x revenue” multiple without checking sector data is one of the most common errors in startup valuation.

Revenue multiples also carry an assumption: that revenue growth will eventually translate into margin. If a business is burning cash with no realistic path to profitability, a high revenue multiple capitalizes future losses rather than future earnings. Experienced buyers discount the multiple when customer concentration is high, gross margins are thin, or growth is decelerating.

Discounted Cash Flow Analysis

Discounted cash flow (DCF) is the most theoretically rigorous method and the one courts tend to favor. Project the company’s free cash flows over a five- to ten-year forecast period, estimate a terminal value for everything after that, and discount both back to today’s dollars at a rate that reflects the risk the cash flows actually materialize.

The Delaware Supreme Court recognized DCF as a legitimate method for determining fair value in a freeze-out merger in Weinberger v. UOP, Inc., noting the focus should be on the target company’s earnings potential.2Justia. Weinberger v. UOP, Inc. – 1983 – Delaware Supreme Court Decisions If your valuation might end up in litigation, a well-documented DCF model is your strongest defense.

Building the Discount Rate

The discount rate is typically the weighted average cost of capital (WACC), which blends the cost of equity and the after-tax cost of debt in proportion to how much of each the company uses.3U.S. Department of Commerce: CLDP. Financial Modeling: CAPM and WACC For negative-EBITDA companies, the cost of equity dominates because these firms typically carry little or no debt.

The cost of equity starts with a risk-free rate. In early March 2026, the 20-year U.S. Treasury yield sat near 4.7%.4Federal Reserve Board. Selected Interest Rates (Daily) Add an equity risk premium of approximately 4.5% as of January 2026,5NYU Stern. Country Default Spreads and Risk Premiums and for a pre-profit startup, layer on further risk adjustments through a higher beta or a company-specific premium. Total discount rates of 20%, 30%, or more are common for early-stage companies. That steep rate is a mathematical expression of uncertainty, and it is why two competent analysts can produce DCF values that disagree by multiples.

Terminal Value

Because the forecast period covers a finite window, you need a terminal value to represent everything after year five or ten. For growth-stage companies, terminal value often accounts for most of the DCF result. The Gordon Growth Model is the standard tool: take the final year’s projected free cash flow, grow it by one year at a stable long-term growth rate, then divide by the discount rate minus that growth rate. Small changes in the assumed growth rate can swing terminal value by tens of millions of dollars, so stress-test this input aggressively.

Asset-Based Valuation

When operations are not generating value, the balance sheet sometimes is. An asset-based valuation tallies the fair market value of everything the company owns (equipment, inventory, real estate, cash, receivables) and subtracts all liabilities. The net asset value represents a floor: the minimum a rational buyer should pay, since they could at least liquidate and walk away whole.

This approach dominates in two situations. Asset-heavy industries like manufacturing, real estate, and natural resources, where physical assets represent most of the company’s worth even when operations are underwater. And distressed sales, where under the U.S. Bankruptcy Code, a sale of a debtor’s property allows secured creditors to bid using their claims against the purchase price, effectively setting a minimum recovery floor.6Office of the Law Revision Counsel. 11 USC 363 – Use, Sale, or Lease of Property

The weakness is clear: asset-based methods ignore the business as a going concern. A biotech firm with two lab benches and $100 million in patents looks nearly worthless on tangible assets alone. For companies whose value lives in intellectual property, customer relationships, or brand, use the methods described below or a dedicated intangibles analysis.

Industry-Specific Performance Metrics

When earnings are negative and revenue is still small, some industries use shorthand metrics that correlate with long-term value. These are not formal valuation methods so much as lenses that tell buyers whether the underlying business is healthy despite the red ink.

  • SaaS companies live by monthly and annual recurring revenue (MRR, ARR), net revenue retention, and churn. The “Rule of 40” adds the revenue growth rate to the free-cash-flow margin, with a combined score of 40% or higher taken as the benchmark for a well-performing SaaS business. The logic: if the company is sacrificing profit for growth, the tradeoff should at least be productive.
  • Consumer tech platforms are measured by daily and monthly active users (DAU, MAU) alongside average revenue per user (ARPU), which lets analysts assign a per-user value based on comparable platform acquisitions.
  • Manufacturing and industrial companies watch the book-to-bill ratio (new orders divided by shipments), which reveals whether demand is building even when current revenue has not caught up.

Venture capital investors tie these metrics directly to deal terms, with funding agreements often including performance milestones keyed to specific KPIs. Missing them can trigger a down round, where the company raises at a lower valuation than before, diluting founders and earlier shareholders through anti-dilution adjustments in preferred stock terms.

Comparable Transaction Analysis

Comparable transaction analysis works like a home appraisal: look at what buyers recently paid for similar businesses and adjust from there. For a negative-EBITDA company, “similar” means matching on industry, growth rate, revenue scale, and stage. Analysts pull data from recent mergers, acquisitions, and IPO filings, usually working with revenue multiples because earnings multiples are unavailable.

If a competitor with a similar revenue profile and negative EBITDA sold for 6x revenue last quarter, that transaction anchors the discussion. SEC Form S-1 registration statements from recent IPOs offer another data point, since they disclose the valuation methodologies the company and its underwriters used to price the offering.7SEC.gov. Form S-1 – Registration Statement Under the Securities Act of 1933 These filings often describe a market approach based on publicly traded comparables, using revenue multiples to estimate enterprise value.

One adjustment that catches people out is the control premium. When a buyer acquires a majority stake, they pay more per share than the public trading price because they gain the ability to change management, redirect strategy, or merge the company. Historical U.S. acquisition premiums have often sat in the 20% to 30% range, but the variation across deals is wide. A well-run target with little room for operational improvement commands a smaller premium than a poorly managed company with obvious fixes. Applying a blanket 25% premium without analyzing the specific situation is a shortcut that leads to overpayment.

The real strength of comparable transactions is as a reality check. A DCF model might produce an enterprise value of $500 million, but if no buyer has paid more than 8x revenue for a company in the sector, that number will not survive the negotiating table.

Valuing Intellectual Property and Intangibles

For many negative-EBITDA companies, the most valuable thing on the balance sheet does not appear on the balance sheet. Patents, proprietary technology, trade secrets, trademarks, and customer lists often represent the real reason a buyer is interested. The World Intellectual Property Organization identifies three main approaches to IP valuation: income-based, market-based, and cost-based.8WIPO. Valuing Intellectual Property Assets

  • The income approach, often called relief from royalty, estimates what the company would pay in royalties to license the IP from a third party, then discounts those hypothetical savings to present value. It is the most common method for patents and trademarks tied to measurable revenue streams.
  • The market approach compares the IP to similar assets that have been sold or licensed, adjusting for differences in scope, remaining life, and market position. The challenge is finding genuinely comparable transactions, since IP is inherently unique.
  • The cost approach calculates what it would cost to recreate the asset from scratch. It works best for software codebases and proprietary processes where reproduction costs are estimable, but it ignores market demand entirely.

In practice, IP valuation often drives the entire deal for a pre-profit company. A pharmaceutical startup with no revenue but a patent protecting a promising drug candidate can be worth hundreds of millions under an income approach applied to projected sales. Buyers in these situations are paying for optionality, and the IP analysis is where that optionality gets priced.

Tax Issues That Change the Price

NOL Limits Under Section 382

A company with negative EBITDA almost certainly has accumulated net operating losses that could offset future taxable income. Those NOLs have real value to an acquirer because they reduce future tax bills. Federal law caps how quickly a buyer can use them after an ownership change.

Under Section 382 of the Internal Revenue Code, when more than 50% of a loss corporation’s stock changes hands within a three-year testing period, the annual amount of pre-change losses that can offset post-change income is capped.9Office of the Law Revision Counsel. 26 USC 382 – Limitation on Net Operating Loss Carryforwards and Certain Built-In Losses Following Ownership Change The cap equals the value of the old loss corporation multiplied by the long-term tax-exempt rate, which is 3.58% for ownership changes in March 2026.10IRS. Rev. Rul. 2026-6 – Rates Under Section 382 Acquire a company valued at $20 million, and you can use only about $716,000 of its pre-change NOLs per year. Pay a premium for $50 million in accumulated losses without modeling this limit, and the economics will not land where you expected.

There is a harsher rule layered on top. If the acquirer does not continue the target’s business enterprise for at least two years after the ownership change, the annual limitation drops to zero and the NOL benefit effectively disappears.9Office of the Law Revision Counsel. 26 USC 382 – Limitation on Net Operating Loss Carryforwards and Certain Built-In Losses Following Ownership Change

Section 409A and Private-Company Stock Pricing

Private companies with negative EBITDA that grant stock options face a separate trap under Section 409A. The exercise price of an option must be set at or above the stock’s fair market value on the grant date. If the IRS later finds the strike price was too low, the employee (not the company) is hit with income inclusion, a 20% additional tax on the deferred compensation, and interest at the underpayment rate plus one percentage point.11Office of the Law Revision Counsel. 26 US Code 409A – Inclusion in Gross Income of Deferred Compensation Under Nonqualified Deferred Compensation Plans

Any private company issuing equity compensation needs a defensible valuation even if it has negative earnings. An independent appraisal from an accredited valuation firm creates a safe harbor that shifts the burden to the IRS to prove the valuation was unreasonable. For companies with no revenue, the asset approach is often the starting point. For companies with revenue but negative earnings, the market approach using comparable company multiples is more common. Skipping the formal valuation creates a tax liability that falls on employees, which is both a legal risk and a retention problem.

If the Company Is Public: Non-GAAP Disclosure Rules

Public companies reporting adjusted EBITDA, revenue multiples, or any other non-GAAP financial measure have to follow specific disclosure rules. Under SEC Regulation G, any public disclosure of a non-GAAP measure must be accompanied by the most directly comparable GAAP measure and a quantitative reconciliation between the two.12eCFR. Part 244 – Regulation G The same requirement applies inside SEC filings under Regulation S-K Item 10(e), which calls for a reconciliation for historical measures and, to the extent available without unreasonable effort, for forward-looking figures.13SEC.gov. Conditions for Use of Non-GAAP Financial Measures

Regulation G includes an anti-fraud provision: a non-GAAP measure that omits material facts or contains untrue statements, taken together with its accompanying information, violates federal securities law.12eCFR. Part 244 – Regulation G For negative-EBITDA companies, the temptation to present an adjusted figure that looks dramatically better than the GAAP number is strongest when the GAAP number is worst. Always read the reconciliation table before accepting any adjusted metric.

What a Professional Valuation Costs

Formal business valuations for small and mid-sized companies (under $10 million in revenue) generally run $2,000 to $10,000 in 2026, depending on complexity, purpose, and whether the report has to meet IRS or litigation standards. Basic internal planning sits at the lower end. A certified report for an IRS submission, a Section 409A safe harbor, or courtroom testimony costs more, because the appraiser documents assumptions in greater detail and stakes their credential on the conclusion.

For a negative-EBITDA company, expect costs toward the higher end. The analyst has to build DCF models with longer projection periods, identify and justify add-backs, value intangible assets separately, and defend a discount rate that reflects above-average risk. Cutting corners on the appraisal to save money frequently costs more in the long run, whether through a mispriced acquisition, an IRS challenge to option grants, or a credibility problem when the valuation is presented to investors or a court.